|
EDF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.204830E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.720620E-01 |
| Normal-vs-Stage2 |
9.456600E-01 |
| Normal-vs-Stage3 |
9.565800E-02 |
| Normal-vs-Stage4 |
5.797600E-03 |
| Stage1-vs-Stage2 |
3.398200E-01 |
| Stage1-vs-Stage3 |
6.092600E-01 |
| Stage1-vs-Stage4 |
5.371600E-02 |
| Stage2-vs-Stage3 |
2.381200E-01 |
| Stage2-vs-Stage4 |
5.044400E-02 |
| Stage3-vs-Stage4 |
2.189600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.998000E-02 |
| Normal-vs-AfricanAmerican |
6.350100E-02 |
| Normal-vs-Asian |
1.831150E-01 |
| Caucasian-vs-AfricanAmerican |
5.540600E-01 |
| Caucasian-vs-Asian |
7.488200E-01 |
| AfricanAmerican-vs-Asian |
4.474400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.433000E-01 |
| Normal-vs-Female |
8.482100E-02 |
| Male-vs-Female |
6.279200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.052200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.445800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.167500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.242020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.877800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.562600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.658400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.446600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.057800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.964400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.669200E-01 |
| Classical-VS-Follicular |
5.57599999999603E-05 |
| Classical-VS-Other |
4.975800E-01 |
| Classical-VS-Normal |
1.217030E-03 |
| Tall-VS-Follicular |
6.846600E-04 |
| Tall-VS-Other |
3.885200E-01 |
| Tall-VS-Normal |
1.211520E-02 |
| Follicular-VS-Other |
3.616000E-01 |
| Follicular-VS-Normal |
1.420590E-01 |
| Other-VS-Normal |
5.526400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.938400E-01 |
| Normal-vs-N1 |
2.214800E-01 |
| N0-vs-N1 |
2.480800E-01 |
|
|
